These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33053366)

  • 1. Vincristine-induced peripheral neuropathy: A mini-review.
    Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
    Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
    Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
    van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
    Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic factors influencing the development of vincristine-induced neurotoxicity.
    Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Cavaletti G
    Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):215-226. PubMed ID: 33283553
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
    Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
    J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
    Triarico S; Romano A; Attinà G; Capozza MA; Maurizi P; Mastrangelo S; Ruggiero A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
    Tunjungsari DA; Gunawan PI; Ugrasena IDG
    J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
    Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
    Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
    Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
    Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
    Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
    Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A cohort study of vincristine-induced peripheral neuropathy in children].
    Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.
    Schouten SM; van de Velde ME; Kaspers GJL; Mokkink LB; van der Sluis IM; van den Bos C; Hartman A; Abbink FCH; van den Berg MH
    Support Care Cancer; 2020 Jun; 28(6):2867-2873. PubMed ID: 31732853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.
    Yang QY; Hu YH; Guo HL; Xia Y; Zhang Y; Fang WR; Li YM; Xu J; Chen F; Wang YR; Wang TF
    Front Pharmacol; 2021; 12():771487. PubMed ID: 34955843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.
    van de Velde ME; van den Berg MH; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van Litsenburg RRL
    Cancer Med; 2021 Nov; 10(22):8172-8181. PubMed ID: 34725942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.
    Egbelakin A; Ferguson MJ; MacGill EA; Lehmann AS; Topletz AR; Quinney SK; Li L; McCammack KC; Hall SD; Renbarger JL
    Pediatr Blood Cancer; 2011 Mar; 56(3):361-7. PubMed ID: 21225912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.
    Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy.
    Joseph EK; Levine JD
    Neuroscience; 2003; 119(3):831-8. PubMed ID: 12809704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and electrophysiological studies in vincristine induced neuropathy.
    Pal PK
    Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.